SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford Health Plan (OXHP)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: men mailman who wrote (319)12/4/1997 10:54:00 PM
From: Jeff Mills  Read Replies (2) of 2068
 
I dont know alot about how HMOs are valued, but right now OXHP has a marketcap of about $1.670 Billion. In the past 12-months, revenues were $3.994 Billion. Currently the price-to-sales ratio on OXHP is 0.42. That's 42› in stock for every $1 in sales they are doing. At its high, OXHPs PSR was 1.76 and the stock was valued at about 7 Billion. If I recall, OXHP said that in 1998 they would see > $5 Billion in revenues. So here is a $5 Billion company valued at $1.67 in the market. There are some shortterm problems, but how low can this stock go? I found the FLA expansion article very bullish and promising and I dont think OXHP would be making those type of comments or expansion if the company was going under. I keep thinking OXHP may be another MEDA--a health-care software company that blew up last year, but upon inspection, MEDA was/is a very small company doing only about $600 MM/year in sales. OXHP is a big company--$4 billion per year is alot of revenue. With that kind of cash flow, it has to look cheap to somebody at $1.67 Billion right now (besides us). Unless the wheels are coming off in big ways and unless they cooked the books, I would be surprised to see OXHP trade below $20. But everything is possible.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext